What R WE reading in the Journal of Comparative Effectiveness Research? A look at the most read articles in November–December 2023

Written by Laura Dormer, Editor

Our bi-monthly column summarizing the most widely read content from our partner journal, the Journal of Comparative Effectiveness Research (JCER).

If you’re interested in contributing to the journal, please get in touch with the Editor of JCER, Laura Dormer, on [email protected]. JCER welcomes unsolicited proposals for articles across a broad range of topics in comparative effectiveness, health economics, outcomes research, pharmacoeconomics and real-world evidence.


Access in all areas? A round up of developments in market access and health technology assessment: part 2

In the latest in our new series of Industry Update articles focusing on market access, Ramagopalan et al. (Lane Clark & Peacock, UK) round-up developments over the past few months, discussing the Inflation Reduction Act, along with price controls and rigid value assessment in Germany.

Read the full article here


Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements

One of the most read and highly cited articles in JCER, this publication presents insights from authors at the University of Calgary, who discuss evidence-based recommendations for early mobilization across enhanced recovery after surgery surgical pathways.

Read the full article here


Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants

Originally published in 2020, this article explores the concepts of propensity score matching and inverse probability of treatment weighting. The authors provide a clinical example, through the utilization of oral anticoagulants for preventing strokes in patients with atrial fibrillation, emphasizing the tangible application of these techniques in comparative effectiveness research.

Read the full article here


Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary

JCER has pioneered the publication of standalone Plain Language Summary of Publication articles (PLSPs), which are plain language, visually enriched articles that provide a summary of a key publication originally published in JCER or another peer-reviewed journal. For more information, visit here.

In this plain language summary of a review article originally published in the journal NPJ Primary Care Respiratory Medicine, the authors discuss the benefits and risks of inhaled corticosteroid use in COPD. The article also includes a video abstract summarising the publication further.

Read the full article here


Institute for Clinical and Economic Review – Peterson Health Technology Institute value assessment framework for digital health technologies

This new White Paper proposes a value assessment framework aimed at guiding the development of digital health technologies (DHTs), serving as the roadmap for future evaluations of DHTs by the Institute for Clinical and Economic Review (ICER) and the Peterson Health Technology Institute (PHTI).

Read the full article here